OURA Ring Wearable Testing in MDS Patients: a Feasibility and Discovery Pilot Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSunnybrook Health Sciences Centre
About this trial
A prospective, single center, single arm phase 2 cohort feasibility study of the OURA ring in adult MDS patients. Patients with MDS will wear the OURA ring and upload biometrics weekly. Quality of life measures will be clinically evaluated and correlated with biometrics. We hypothesize that it will be feasible for MDS patients to wear the OURA ring 70% of the time for 3 months.
Eligibility criteria
Qualifiers
Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
Male or female, aged 18 or older
Able to read, write and speak English or French (non-English or French speaking patients may participate if appropriate translation is used)
Disqualifiers
Performance status ECOG > 3.
Cognitive or physical impairment preventing the usage or utilization of the OURA ring and smart phone.
Trial design
Treatments tested in this trial
- OURA Ring
Treatment groups
60 Participants
are divided into 2 treatment groupsLocations
1Sunnybrook Health Sciences Research CentreM4N 3M5, TorontoOntario, Canada
Sponsors and collaborators
Sunnybrook Health Sciences Centre
Lead sponsor
Source ClinicalTrials.gov